48
The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas; King’s College, London, UK

The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

  • Upload
    others

  • View
    3

  • Download
    1

Embed Size (px)

Citation preview

Page 1: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

The Human Microbiome in Medicine

IMI Stakeholders Forum

October 19, 2017, Brussels, Belgium

S. Dusko Ehrlich,

MetaGenoPolis, INRA Jouy en Josas; King’s College, London, UK

Page 2: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

The human intestinal microbiome is a neglected organ

100 trillion microorganisms ; more cells than the human body; up to 2 kg of mass!

Interface between food and epithelium

In contact with the 1st pool of immune cells and the 2nd pool of neural cells of the body

An organism can function well when all its organs function well

Page 3: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Multiple functions of the neglected organ

Page 4: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

The gut microbiome appears altered in many chronic diseases

Seven of the top 10 causes of death in 2010 were chronic diseases. Two of these—heart disease and cancer—accounted for nearly 48% of deaths in the US Centers for Disease Control and Prevention, 2013

Page 5: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

NL254

Gen

e co

un

t

DK SPn 123 111

USA CN138 19

Healthy PatientsUC fistula CDObese NASHT1D T2D

FR143169 239 196 36 60

SpaniardsDK31

DK78

DK FR

10-24

10-7

10-2

10-2

10-14

10-3

10-2

10-10

A common alteration is loss of microbial richness

HGC

LGC

Atrophy of the neglected organ

Page 6: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Microbial richness can be lost even in healthy people

Low HighGene count

n=277

Low gene count individuals (1/4) have increased adiposity, insulin resistance, dyslipidaemia & inflammation – a risk for chronic diseases

Le Chatelier et al. Nature 2013, doi: 10.1038/nature12506.

Page 7: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Mucus layer

Host tissues

Methanobrevibacter ↓

Lactate ↓

H2 ↓

Bififobacterium

shunt ↓

Microbialrichness↓

Mucus

degradation↑

Bacteroides↑

H2S ↑ Sulfate

reduction↑

Ruminococcus

gnavus/torques↑

Proteobacteria↑

Western-type

dietary pattern Endotoxemia

BMI/IR/

Inflammation↑

Butyrate ↓

Oxygen tolerance/

Oxidative stress response↑

CH4 ↓

LPS/Pathogen/Proteobacteria

driven inflammatory switch

Repeated AB

treatment?

Lachnospiraceaea↓

Akkermansia ↓

Reduced gut

lining integrity

Gut lumen - LGC microbiota

Microbe-poor gut microbiome is less healthy

Le Chatelier et al. Nature 2013, doi: 10.1038/nature12506.

Low butyrate, high LPS, high H2S, oxidative stress

Page 8: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Microbiome richness is associated with health and well-being

It is better to be rich than poor

We need more gut bacteria!

Page 9: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

Quan ta vemetagenomicsSample

collec onSequencing

Reference

construc onGeneprofiling

Mappingtogenecatalog

Stoolsample

TotalDNA NGS

20millionsequences

ReferenceGeneCatalog

Bioinforma cs&sta s csanalyses

Preprocessing/normaliza onanddimension

reduc on

Iden fyrelevantmicrobialplayers

Buildandtestpredic onmodels

Genecounts

genes

individuals Relatetohumandata

Knowngenomes

Standardization is critical for quantitative metagenomics http://www.microbiome-standards.org/#SOPS

Microbiome alterations can be very accurately detected by full sequencing

Costea et al. NatBiotech 2017

Page 10: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

An integrated 9.9 M genes reference catalog

Individuals from MetaHIT, Chinese and HMP studies, n=1267Sequenced reference gut genomes

Rare genes are increasing - Transient species ?- Strain differences ?Pan-metagenome

Li et al. Nature Biotech, 2014

Common genes are not They may be most clinically useful for common diseases

March 2010124 individuals3.3 M genes

Page 11: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Improving microbiome description

Page 12: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

N=400

N=120

N=1267N=134

N=85

Infant gut microbial catalog containing 13 M genes

Anne Sophie Alvarez et al, in preparation

2006 individuals739 kids, 1 week to 6 yrs1267 adults

Gene detection in 6 weeks old infants is greatly augmented

Metahit 9.9M : 53,151 genes Infant 13M : 128,750 genes

Gene count

9.9M 13M

Page 13: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Rheumatoid arthritis catalogLiver cirrhosis catalogVegan catalogAtherosclerosis catalog ….

Comparability of studies requires a common catalog – we should cooperate

to make it and update it!

Towards a common gut gene catalog

Page 14: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

Animal models Mouse gut - 184 animals, different providers,

housing institutions and diets, 2.5 M genes5% overlap with the human gene catalog (Xiao et al., Nat Biotech 33, 1103-1108, 2015)

Pork gut – 287 pigs from France, Denmark and China, 7.7 million genes (Nat Microb, 2016)12% overlap with the human gene catalog

Bovine, chicken, rabbit gut – under construction

Other human sites Oral gene catalog – 300+ individuals, ~13 M genes

(Cabrero et al. in preparation)

Page 15: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

741 large MGU (>700 Genes) correspond to bacterial species (MetaGenomic Species; 85% previously unknown)238 high quality genomes reconstructed6640 small MGU: phages, plasmids, virulence islands, CRISPR..

Nielsen, et al. Nature Biotech, 2014

Gene catalog clustered in MetaGenomic Units by co-abundance binning

MGSMGU

Interaction network

9.9 M MetaHit: ~1 500 MGS & ~12 000 MGU

Page 16: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

By systematic culturing, enabling characterization of playersBy computational means, enabling strain and pangenome assessment

Empowering reasoned microbiome modulation

Improving knowledge of human associated microbial species

Page 17: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Diagnostics

Page 18: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Discovery•98 patients • 83 controls

Validation• 25 patients• 31 controls

Liver cirrhosis

Qin N. et al. Nature 2014, doi: 10.1038/nature13568. Zhejiang University, Hangzhou, China & MGP, Jouy en Josas, France

123 patients Liver cirrhosis diagnosis • by biopsy in 46• by clinical symptoms or imaging in 77

114 controlsHealthy volunteers who visited the hospital for annual physical examination

AUC = 0.943 AUC = 0.935

Page 19: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Parkinson disease

Bedarf … Bork et al., Genome Biology, 2017

Cotillard et al. Nature 2013

Rich and poor microbiome

Atherosclerosis

Zhie … Karstensen et al., Nat Comm, 2017

Page 20: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Microbiome-based biomarkers can accurately detect a disease

and even a risk of a disease

6 MGS identify at-risk individuals that are

microbe-poor with 95% accuracy

Cotillard et al. Nature 2013, doi: 10.1038/nature12480.39

Page 21: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Severity of the disease – liver cirrhosis

Qin N. et al. Nature 2014

MELD CTP

p<1e-5 p<3e-4

LC MGS load

Low High Low High

MG

S en

rich

ed in

LC

n

=28

MG

S en

rich

ed in

Hea

lth

y n

= 3

8

Healthyn=98

LCn=83

Invasion of the gut by oral bacteria

Oral

Overproduction of NH3 & GABA; impact on Mn2+

Page 22: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Current concepts in the assessment and treatment of Hepatic EncephalopathyW.J. Cash, P. McConville , E. McDermott, P.A. McCormick, M.E. Callender, N.I. McDougall, 2009. DOI: http://dx.doi.org/10.1093/qjmed/hcp152

Pathophysiology – impacted by the microbiome?The ammonia theoryGABA/benzodiazepine receptor complex theoryManganese theory

Treatments – impact the microbiome?Oral laxativesEnemasAntibiotics

Page 23: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Treatments to improve the microbiome more permanently - FMT?

Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial Bajaj et al 2017, DOI: 10.1002/hep.29306

FMT, n=10; Standard of care, n=10, Follow-up 150 days

Conclusions: FMT … reduced hospitalizations, improved cognition and dysbiosis in cirrhosis with recurrent HE.

Page 24: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Trigger: Virus infection, alcohol, obesity, autoimmunity… Consequence:

Loss of hepatocytes, impaired bile production – gut ecosystem becomes permissive to bile-intolerant microbesResult:

Invasion of the gut by oral bacteria & food-borne pathogens - advent of a toxic microbiomeAvenues for new treatments:FMT to restore a healthy microbiome Administration of bile salts (or equivalents) to protect it!?

Advent of toxic microbiome in liver cirrhosis

Cause, consequence…

Page 25: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Treating the human and the microbial parts of our body to optimally preserve health and

cure the disease

human

microbialchange change

Page 26: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Alterations of the microbiome can aggravate the disease;

restoration of the microbiome should be beneficial

Page 27: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Microbiome restorationDiet, nutritional interventions Molecules • Promoters of “good” species (prebiotics, fibers)• Inhibitors of “bad” species (narrow spectrum AB,

bacteriocins)Microbes• Bacteriophages• Probiotics• Communities• Transplantation

Page 28: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Nutritional intervention can impact richness

Page 29: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Dietary intervention improves simultaneously gene richness and risk phenotypes

Low

High

Low

High

Risk mitigation by interventionCotillard et al. Nature 2013, doi: 10.1038/nature12480.39 .

Page 30: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

The communities of the gut microbiome

Page 31: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

Europeans, Americans, Asians, n=33.

Danesn=85

USn=154

Based on genus-level analysisNamed after the dominant genus

Page 32: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Quest for mechanisms – single species or communities?

Page 33: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Integration of clinical phenotypes, microbiome and

metabolome data reveals microbial species important for

a disease

Pedersen et al. Nature 2016, 535, 376-381.

Page 34: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

Microbiome and insulin resistance

277 non-diabetic individuals 75 T2D patients

The IR-associated metabolome was associated with the gut microbiome-encoded functions:

Higher potential for LPS and BCAA biosynthesis Reduced potential for BCAA transport into bacterial cells

Pedersen et al. Nature 2016, 535, 376-381.

Page 35: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

A few species drive the associationPositive correlations between microbial functions and IR are largely driven by a few species, notably Prevotella copri and Bacteroides vulgatus, suggesting that they may directly impact host metabolism. We tested this hypothesis in mice on a high-fat diet, and found that a challenge with P. copri led to increased circulating serum levels of BCAAs and insulin resistance.

sham P. copri

Pedersen et al. Nature 2016, 535, 376-381.

Page 36: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

A single species can play an important role but many are likely to contribute

Page 37: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Is microbiome alteration a cause, a consequence or a contribution to a

chronic disease?

Page 38: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Contribution of the microbiome to the disease – two examples

Liver cirrhosis gut microbiome may be toxicAmmoniac, manganese, GABA (encephalopathy)

Low richness gut microbiome may be less healthy Low butyrate producers (gut health)Abundant pro-inflammatory species (systemic inflammation)

The advent of vicious cycle: inflammation selects for resistant species, which are pro-inflammatory.

Page 39: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

We should strive to restore or preserve health by modulating unhealthy/toxic microbiome and treating the host, to

break the vicious cycle…

…while attempting to unravel the mechanisms which underlie its advent

and its effects on our bodies

Page 40: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Understanding mechanisms Cell lines, high throughput screens for microbe-derived effectors Organoids Artificial organs (gut) to characterize microbial interactions Animal models to study host-microbe dialogue Interventional longitudinal studies

…will take time

Page 41: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Impact of human microbiome research on health

A tremendous potential of human microbiome

• diagnostics• prognostics• patient monitoring• target for modulation to improve health

To better preserve health and better treat the disease

Industry-academia partnering

Page 42: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

MetaGenoPolisPre-industrial Demonstrator

Grant P.I. : S. Dusko EhrlichDirector of the INRA Unit: Florence HaimetDirector of Research: Joël Doré

Funding: 19M€ for 2012-2020 by Investissements d’AvenirBudget for the period: 60+ M€

Microbiome in health & disease

Page 43: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

43

Hôpital Pitié-SalpêtrièreICAN CLINICAL STUDIES

A set of ISO9001-2015 certified platforms

Page 44: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

October 2017

Landmark human microbiome papers

2010 : Qin et al. Nature , The human gut reference catalogue 2011 : Arumugam et al. Nature, Enterotypes2012 : Qin et al. Nature, Type II Diabetes 2013 : Cotillard et al. Nature, Impact of diet on gut microbiome2013 : Le Chatelier et al. Nature, Richness of gut microbes and metabolic markers2013 : Sunagawa et al. Nature Methods, Universal phylogenetic markers2014 : Nielsen et al. Nature Biotech, Method for identifying metagenomic species 2014 : Li et al. Nature Biotech, 10 millions genes reference catalog 2014 : Qin et al. Nature, Human gut microbiome alterations in liver cirrhosis2015 : Xiao et al. Nature Biotech, A mouse gut catalogue2015 : Qin et al. Nature, Accurate liver cirrhosis diagnostic, 2015 : Forslund et al. Nature, Drug confounders in microbiome analysis2016 : Pedersen et al. Nature, Microbiome & insuline resistance2017 : Costea et al. Nature Biotech, Standards for microbiome studies

► 60+ publications on quantitative & functional Metagenomics

► 29 patent applications, 70% licensed ► 24 M € research contracts, 54% private sources

Page 45: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

CONFIDENTIAL

http://www.enterome.com/

Gut bacterial richness scan on a Q-PCR & nanostring platforms

Beyond discovery : impact on the society –engaging industry

To fix IBD… look at the MicrobiomeTHE FIRST NONINVASIVE GUT MICROBIOME BIOMARKER surrogate marker of

mucosal healing

Page 46: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

Acknowledgments

Micro-Obese: K. Clement, JD. Zucker, J. Doré

MetaHIT Consortium

Page 47: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

47

The team

Sambo

InfoBioStat

MetaFun

Nicolas PONSAnne-Sophie ALVAREZAriane BASSIGNANIKevin DA SILVAMagali BERLANDFranck GAUTHIERSebastian FROMENTINSusie GuillyMarie JEAMMETHana JULIENNEEmmanuelle LECHATELIERPierre LeonardNicolas MAZIERSFlorian PLAZA ONATEFlorence THIRIONKevin WEISZER

MetaQuant

Hugues ROUMENathalie GalleronBenoit QUINQUISMélina CORDEAUGwenolah ANNONAY

Florence LEVENEZMickael CAMUSMylène ROBINET

Hervé BLOTTIEREVéronique LEJARDParfait EVOUNA-MENGUEAmélie GOUDETAline LETUR

Florence HAIMETAnne BoninAnthony DOBEZMarine FRAISSANGEDamien TOTY

Florence HAIMETJoël DORE

Transversal services

InfoBioStat

Sambo

MetaQuant

MetaFun

Page 48: The Human Microbiome in Medicine...The Human Microbiome in Medicine IMI Stakeholders Forum October 19, 2017, Brussels, Belgium S. Dusko Ehrlich, MetaGenoPolis, INRA Jouy en Josas;

Merci beaucoup,Thank you very much!

And take good care of your microbiome…

www.mgps.eu